ExodusPoint Capital Management’s Wave Life Sciences WVE Stock Holding History

ExodusPoint Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Buy	+251,072	New	+$1.66M	0.01%	956
2025 Q4	–	Sell	-94,080	Closed	-$689K	–	2135
2025 Q3	$689K	Buy	94,080 +83,816	+817%	+$678K	0.01%	1084
2025 Q2	$67K	Sell	10,264 -86,004	-89%	-$568K	﹤0.01%	1368
2025 Q1	$778K	Buy	+96,268	New	+$1.05M	0.01%	988
2021 Q4	–	Sell	-18,381	Closed	-$90K	–	2653
2021 Q3	$90K	Sell	18,381 -48,797	-73%	-$296K	﹤0.01%	1919
2021 Q2	$447K	Buy	+67,178	New	+$439K	﹤0.01%	1516
2021 Q1	–	Sell	-36,793	Closed	-$290K	–	2675
2020 Q4	$290K	Sell	36,793 -64,994	-64%	-$546K	﹤0.01%	1557
2020 Q3	$864K	Buy	101,787 +55,024	+118%	+$603K	0.02%	749
2020 Q2	$487K	Buy	+46,763	New	+$440K	0.01%	1101
2019 Q3	–	Sell	-18,650	Closed	-$487K	–	1681
2019 Q2	$487K	Buy	+18,650	New	+$523K	0.02%	488

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

ExodusPoint Capital Management's WVE Position: Q2 2026 in Review

ExodusPoint Capital Management opened a new position in Wave Life Sciences (WVE) in Q2 2026: 251,072 shares worth $1.46M. The stake represents 0.01% of the portfolio and ranks #956 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in WVE as recently as Q3 2025.

ExodusPoint Capital Management first reported a position in WVE in Q2 2019 and has held it in 10 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

ExodusPoint Capital Management held 251,072 shares of Wave Life Sciences worth $1.46M as of Q2 2026.
Wave Life Sciences was a new ExodusPoint Capital Management position in Q2 2026.
Wave Life Sciences made up 0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #956 holding.
ExodusPoint Capital Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 10 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.